BiotechTube

Tadalafil + Placebo + Finasteride

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Benign Prostatic Hyperplasia

Conditions

Benign Prostatic Hyperplasia, Enlarged Prostate

Trial Timeline

Sep 1, 2010 → May 1, 2012

NCT ID
NCT01139762

About Tadalafil + Placebo + Finasteride

Tadalafil + Placebo + Finasteride is a phase 3 stage product being developed by Eli Lilly for Benign Prostatic Hyperplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT01139762. Target conditions include Benign Prostatic Hyperplasia, Enlarged Prostate.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01139762Phase 3Completed

Competing Products

20 competing products in Benign Prostatic Hyperplasia

See all competitors
ProductCompanyStageHype Score
Tadalafil + PlaceboEli LillyPhase 3
77
5 mg Tadalafil + Placebo + 0.2 mg TamsulosinEli LillyPhase 3
77
Placebo + tadalafilEli LillyPhase 3
77
Tadalafil + Placebo + Alpha1 BlockerEli LillyApproved
85
Placebo tamsulosin hydrochloride OCAS 0.4 mg + Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg + Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg + tamsulosin hydrochloride OCAS 0.4 mg + tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) + tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)Astellas PharmaPhase 3
77
Mirabegron + Placebo + Tamsulosin HydrochlorideAstellas PharmaApproved
85
ASP4901 + Tamsulosin + PlaceboAstellas PharmaPhase 2
52
Tamsulosin hydrochloride + Solifenacin succinateAstellas PharmaApproved
85
Tamsulosin OCASAstellas PharmaApproved
85
Tamsulosin OCAS + PlaceboAstellas PharmaApproved
85
Tamsulosin + Finasteride + PlaceboAstellas PharmaApproved
85
Tadalafil + PlaceboEli LillyPhase 2
52
TadalafilEli LillyPhase 1
33
Tadalafil + Placebo + TamsulosinEli LillyPhase 3
77
Tadalafil 2.5 mg + Tadalafil 5 mg + PlaceboEli LillyPhase 2
52
Tadalafil 5 mg + Placebo tablet + Tamsulosin + Placebo capsuleEli LillyPhase 3
77
Tadalafil + PlaceboEli LillyPhase 3
77
Tadalafil + Placebo + TamsulosinEli LillyPhase 2
52
Tadalafil + PlaceboEli LillyPhase 3
77
tadalafil + tadalafil + tadalafil + tadalafil + placeboEli LillyPhase 2/3
65

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85